Guardant Health (GH) Long-Term Investments (2017 - 2022)

Guardant Health has reported Long-Term Investments for 6 years, with the latest figure at $156.7 million in Q3 2022.

• Quarterly Long-Term Investments fell 37.36% year-over-year to $156.7 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $156.7 million (down 37.36% YoY) and the FY2021 annual result came in at $698.0 million, up 183.07% from the prior year.
• Long-Term Investments fell to $156.7 million in Q3 2022 per GH's latest filing, from $382.6 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $698.0 million in Q4 2021 and troughed at $3.0 million in Q3 2018.
• A 5-year average of $235.6 million and a median of $242.4 million in 2020 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2019 and 2020: Long-Term Investments soared 10113.43% in 2019, then slumped 83.02% in 2020.
• Over 5 years, Long-Term Investments stood at $77.6 million in 2018, then surged by 246.54% to $268.8 million in 2019, then decreased by 8.25% to $246.6 million in 2020, then soared by 183.07% to $698.0 million in 2021, then tumbled by 77.55% to $156.7 million in 2022.
• According to Business Quant data, Long-Term Investments over the past three periods registered $156.7 million, $382.6 million, and $588.5 million for Q3 2022, Q2 2022, and Q1 2022 respectively.